289 related articles for article (PubMed ID: 22587646)
1. Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the art.
Martino M; Fedele R; Cornelio G; Moscato T; Imbalzano L; Ressa G; Massara E; Bresolin G
Expert Opin Biol Ther; 2012 Aug; 12(8):1017-30. PubMed ID: 22587646
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal photochemotherapy.
Maeda A
J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photopheresis: what is it and when should it be used?
Scarisbrick J
Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD).
Rutella S; Valentini CG; Ceccarelli S; Romano MT; Brescia LP; Milano GM; Locatelli F
Transfus Apher Sci; 2014 Jun; 50(3):340-8. PubMed ID: 24780391
[TBL] [Abstract][Full Text] [Related]
5. Extracorporeal photochemotherapy--present and future.
Knobler R
Vox Sang; 2000; 78 Suppl 2():197-201. PubMed ID: 10938952
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal photopheresis: a review on the immunological aspects and clinical applications.
Chiesa-Fuxench ZC; González-Chávez J
P R Health Sci J; 2010 Dec; 29(4):337-47. PubMed ID: 21261172
[TBL] [Abstract][Full Text] [Related]
7. Current clinical applications of extracorporeal photochemotherapy.
Capuano M; Sommese L; Pignalosa O; Parente D; Fabbricini R; Nicoletti GF; De Pascale MR; Schiano C; Napoli C
Ther Apher Dial; 2015 Apr; 19(2):103-10. PubMed ID: 25363837
[TBL] [Abstract][Full Text] [Related]
8. Analysis of clinical outcome and survival in pediatric patients undergoing extracorporeal photopheresis for the treatment of steroid-refractory GVHD.
González Vicent M; Ramirez M; Sevilla J; Abad L; Díaz MA
J Pediatr Hematol Oncol; 2010 Nov; 32(8):589-93. PubMed ID: 20962677
[TBL] [Abstract][Full Text] [Related]
9. Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?
Marshall SR
Nat Clin Pract Oncol; 2006 Jun; 3(6):302-14. PubMed ID: 16757968
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease.
Fimiani M; Di Renzo M; Rubegni P
Br J Dermatol; 2004 Jun; 150(6):1055-60. PubMed ID: 15214889
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photopheresis: technique, established and novel indications.
Marques MB; Adamski J
J Clin Apher; 2014 Aug; 29(4):228-34. PubMed ID: 24828404
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients.
Quaglino P; Comessatti A; Ponti R; Peroni A; Mola F; Fierro MT; Savoia P; Novelli M; Bernengo MG
Int J Immunopathol Pharmacol; 2009; 22(2):353-62. PubMed ID: 19505389
[TBL] [Abstract][Full Text] [Related]
14. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
[TBL] [Abstract][Full Text] [Related]
17. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD).
Child FJ; Ratnavel R; Watkins P; Samson D; Apperley J; Ball J; Taylor P; Russell-Jones R
Bone Marrow Transplant; 1999 May; 23(9):881-7. PubMed ID: 10338042
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report.
Berger M; Pessolano R; Albiani R; Asaftei S; Barat V; Carraro F; Biasin E; Madon E; Fagioli F
J Pediatr Hematol Oncol; 2007 Oct; 29(10):678-87. PubMed ID: 17921848
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal photopheresis: a review.
Oliven A; Shechter Y
Blood Rev; 2001 Jun; 15(2):103-8. PubMed ID: 11409910
[TBL] [Abstract][Full Text] [Related]
20. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
